2020-2025 Global Cilastatin Sodium Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
- 139225
- 25-May
- Pharmaceutical
- 104
- MRR
-
Report Details
Cilastatin sodium is a renal dehydropeptidase-I and leukotriene D4 dipeptidase inhibitor. Since the antibiotic, IMIPENEM, is hydrolyzed by dehydropeptidase-I, which resides in the brush border of the renal tubule, cilastatin is administered with imipenem to increase its effectiveness. The drug also inhibits the metabolism of leukotriene D4 to leukotriene E4. This report elaborates the market size, market characteristics, and market growth of the Cilastatin Sodium industry, and breaks down according to the type, application, and consumption area of Cilastatin Sodium. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Cilastatin Sodium in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19. In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy. Key players in the global Cilastatin Sodium market covered in Chapter 13: Merck Ranbaxy Laboratories United Laboratories Pfizer Shenzhen Haibin Pharmaceutical In Chapter 6, on the basis of types, the Cilastatin Sodium market from 2015 to 2025 is primarily split into: Powder Solid In Chapter 7, on the basis of applications, the Cilastatin Sodium market from 2015 to 2025 covers: Aerobic infection Anaerobic infection Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5: United States Europe China Japan India Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12: North America (Covered in Chapter 8) United States Canada Mexico Europe (Covered in Chapter 9) Germany UK France Italy Spain Others Asia-Pacific (Covered in Chapter 10) China Japan India South Korea Southeast Asia Others Middle East and Africa (Covered in Chapter 11) Saudi Arabia UAE South Africa Others South America (Covered in Chapter 12) Brazil Others Years considered for this report: Historical Years: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Period: 2020-2025
-
Table Of Content
Table of Content 1 Cilastatin Sodium Market - Research Scope 1.1 Study Goals 1.2 Market Definition and Scope 1.3 Key Market Segments 1.4 Study and Forecasting Years 2 Cilastatin Sodium Market - Research Methodology 2.1 Methodology 2.2 Research Data Source 2.2.1 Secondary Data 2.2.2 Primary Data 2.2.3 Market Size Estimation 2.2.4 Legal Disclaimer 3 Cilastatin Sodium Market Forces
-
Inquiry Before Buying
-
Request Sample